drugset / Trial / NCT00830375

Memantine Treatment of Compulsive Buying

NCT00830375

Phase 2 Completed 10 enrolled University of Minnesota
NaSingle-groupOpen-labelTreatment

Summary

This is an 8-week, open-labe study of memantine in the treatment of compulsive buying.

Timeline

Start
2008-12-01
Primary completion
2010-08-01
Completion
2010-08-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Memantine Unknown 10 mg Oral
Subject Memantine Unknown 30 mg Oral

Indications